Aldosterone blockade in patients with heart failure and a reduced left ventricular ejection fraction
- PMID: 19190013
- DOI: 10.1093/eurheartj/ehp026
Aldosterone blockade in patients with heart failure and a reduced left ventricular ejection fraction
Comment on
-
Aldosterone blockade and left ventricular dysfunction: a systematic review of randomized clinical trials.Eur Heart J. 2009 Feb;30(4):469-77. doi: 10.1093/eurheartj/ehn543. Epub 2008 Dec 9. Eur Heart J. 2009. PMID: 19066207
Similar articles
-
Treatment of heart failure with normal ejection fraction in patients with advanced chronic heart failure.Eur J Heart Fail. 2007 Dec;9(12):1223; author reply 1224-5. doi: 10.1016/j.ejheart.2007.09.007. Epub 2007 Nov 19. Eur J Heart Fail. 2007. PMID: 18006377 No abstract available.
-
Sudden cardiac death after heart failure; symptomatic versus disease treatment? An editorial comment.Heart Fail Rev. 2004 Oct;9(4):347-51. doi: 10.1007/s10741-005-7032-8. Heart Fail Rev. 2004. PMID: 15886980 No abstract available.
-
Pharmacotherapy for heart failure with left ventricular dysfunction: beyond angiotensin-converting enzyme inhibitors and beta-blockers.Pharmacotherapy. 2008 Jul;28(7):920-31. doi: 10.1592/phco.28.7.920. Pharmacotherapy. 2008. PMID: 18576907 Review.
-
Pharmacological treatment of heart failure with preserved ejection fraction: a glimpse of light at the end of the tunnel?Eur J Heart Fail. 2013 Jan;15(1):5-8. doi: 10.1093/eurjhf/hfs194. Epub 2012 Nov 28. Eur J Heart Fail. 2013. PMID: 23193144 No abstract available.
-
Heart Failure Society of America (HFSA) practice guidelines. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction--pharmacological approaches.J Card Fail. 1999 Dec;5(4):357-82. J Card Fail. 1999. PMID: 10634677 Review. No abstract available.
Cited by
-
Association between spironolactone added to beta-blockers and ACE inhibition and survival in heart failure patients with reduced ejection fraction: a propensity score-matched cohort study.Eur J Clin Pharmacol. 2013 Oct;69(10):1747-55. doi: 10.1007/s00228-013-1512-x. Epub 2013 Jun 7. Eur J Clin Pharmacol. 2013. PMID: 23743778
-
Optimal antagonism of the Renin-Angiotensin-aldosterone system: do we need dual or triple therapy?Drugs. 2010 Jul 9;70(10):1215-30. doi: 10.2165/11537910-000000000-00000. Drugs. 2010. PMID: 20568830 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical